Cambridge Bioscience partners with BPS Bioscience to provide their products within the UK and Ireland.
The extensive portfolio from BPS Bioscience aims to advance new scientific discoveries that lead to therapies. With a particular focus on immunotherapy, epigenetics, coronavirus, CRISPR, and cell signalling, BPS Bioscience provide over 4000 high quality recombinant cell lines, lentiviruses, proteins and all aspects of biochemical and cell-based assay development to accelerate your research.
Learn more about BPS Bioscience or contact our BPS Bioscience specialists.
Published
06 Oct 2023